The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease
Abstract
We measured serum bone alkaline phosphatase (B-ALP) with a new immunoradiometric assay (IRMA) in a large sample of healthy controls comprising 173 women and 180 men, 20-88 yr of age, and in patients with metabolic bone disease. Using serum samples from patients with liver disease and patients with Paget's disease with elevated total alkaline phosphatase (T-ALP) as a source of, respectively, liver and bone isoenzymes, we determined a liver cross-reactivity of the IRMA of 16% that was confirmed by electrophoresis of the circulating alkaline phosphatase isoenzymes. The IRMA was linear for serial sample dilutions, the recovery ranged from 89-110%, and the intra- and interassay variations were below 7% and 9%, respectively. B-ALP increased linearly with age in both sexes, and the mean B-ALP serum levels were not significantly different for women and men (11.3 +/- 4.8 ng/mL for women; 11.0 +/- 4.0 ng/mL for men). The increase in B-ALP after the menopause was significantly higher than that in T-ALP (+77% vs. +24%; P < 0.001). When the values of postmenopausal women were expressed as the SD from the mean of premenopausal women, the mean Z scores were 2.2 +/- 1.8 for B-ALP and 0.9 +/- 1.3 for T-ALP (P < 0.001 between the two). Serum B-ALP was increased from control values in patients with Paget's disease (n = 57; mean, 171.8 +/- 135.6 ng/mL; P < 0.001), in patients with primary hyperparathyroidism (n = 18; mean, 17.2 +/- 5.9 ng/mL; P < 0.001), and in patients with chronic renal failure on hemodialysis (n = 83; mean, 36.6 +/- 35.7 ng/mL; P < 0.001). In patients with Paget's disease, B-ALP was highly correlated with T-ALP (r2 = 0.94; P < 0.001), and the decrease in its serum level was larger than that in T-ALP after treatment with the bisphosphonate pamidronate (-58% vs. -43%; P < 0.03). In patients with various liver diseases, B-ALP was slightly increased, but stayed within the normal range (mean +/- 2 SD) until T-ALP did not exceed 4.5 mu katal/L. We conclude that this new IRMA for B-ALP is reliable, has a low cross-reactivity with the liver isoenzyme, and appears to be more sensitive than T-ALP for the clinical investigation of patients with osteoporosis and other metabolic bone diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis: Etiology, diagnosis, and management
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80791-1 · Cited by 605
The human alkaline phosphatases: What we know and what we don't know
Harris, H. (1990) · Clinica Chimica Acta · doi:10.1016/0009-8981(90)90031-m · Cited by 505
Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.
Price, P. A., Williamson, M. K., & Lothringer, J. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42960-2 · Cited by 485
Weiss, M. J., Henthorn, P. S., Lafferty, M. A., Slaughter, C., Raducha, M., & Harris, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7182 · Cited by 398
Delmas, P. D., Stenner, D., Wahner, H. W., Mann, K. G., & Riggs, B. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110882 · Cited by 353
EASTELL, R., DELMAS, P. D., HODGSON, S. F., ERIKSEN, E. F., MANN, K. G., & RIGGS, B. L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-741 · Cited by 273
Rosalki, S. B., & Foo, A. Y. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.7.1182 · Cited by 258
DUDA, R. J., O’BRIEN, J. F., KATZMANN, J. A., PETERSON, J. M., MANN, K. G., & RIGGS, B. L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-5-951 · Cited by 248
DIFFERENCES IN SERUM BONE GLA PROTEIN WITH AGE AND SEX
Epstein, S., Mcclintock, R., Bryce, G., Poser, J., Johnston, C., & Hui, S. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90360-x · Cited by 194
Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
Garnero, P., Grimaux, M., Demiaux, B., Preaudat, C., Seguin, P., & Dr. Delmas, P. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071206 · Cited by 183
Self-citation
Cited by
Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,637
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Self-citationIncreased bone turnover in late postmenopausal women is a major determinant of osteoporosis
Dr. Garnero, P., Sornay-Rendu, E., Chapuy, M.-C., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110307 · Cited by 1,001
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M.-C., Marcelli, C., Grandjean, H., Muller, C., Cormier, C., Bréart, G., Meunier, P. J., & Dr. Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 989
Self-citationGarnero, P., Sornay-Rendu, E., Claustrat, B., & Delmas, P. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1526 · Cited by 709
Self-citationGarnero, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1693 · Cited by 707
Self-citationBass, S., Pearce, G., Bradney, M., Hendrich, E., Delmas, P. D., Harding, A., & Seeman, E. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.500 · Cited by 616
Pols, H. A. P., Felsenberg, D., Hanley, D. A., Štepán, J., Muñoz-Torres, M., Wilkin, T. J., Qin-sheng, G., Galich, A. M., Vandormael, K., Yates, A. J., et al. (1999) · Osteoporosis International · doi:10.1007/pl00004171 · Cited by 593
Journal of Bone and Mineral Research
Delmas, P. D. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081323 · Cited by 454
The differing tempo of growth in bone size, mass, and density in girls is region-specific
Bass, S., Delmas, P. D., Pearce, G., Hendrich, E., Tabensky, A., & Seeman, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7060 · Cited by 413
Bauer, D. C., Black, D. M., Garnero, P., Hochberg, M., Ott, S., Orloff, J., Thompson, D. E., Ewing, S. K., Delmas, P. D., & for the Fracture Intervention Trial Study Group (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040512 · Cited by 405
Self-citationVergnaud, P., Garnero, P., Meunier, P. J., Bréart, G., Kamihagi, K., & Delmas, P. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3805 · Cited by 389
Self-citationBone Turnover Markers: Basic Biology to Clinical Applications
Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac031 · Cited by 387
Relationship of Bone Turnover to Bone Density and Fractures
Melton, L. J., Khosla, S., Atkinson, E. J., O'Fallon, W. M., & Riggs, B. L. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1083 · Cited by 350
Clinical Utility of Biochemical Markers of Bone Remodeling
Watts, N. B. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1359 · Cited by 336
Chapuy, M. C. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.1129 · Cited by 334
Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum
Gomez, B., Ardakani, S., Ju, J., Jenkins, D., Cerelli, M. J., Daniloff, G. Y., & Kung, V. T. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.11.1560 · Cited by 312
Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans
Collet, P., Uebelhart, D., Vico, L., Moro, L., Hartmann, D., Roth, M., & Alexandre, C. (1997) · Bone · doi:10.1016/s8756-3282(97)00052-5 · Cited by 290
Ensrud, K. E., Barrett-Connor, E. L., Schwartz, A., Santora, A. C., Bauer, D. C., Suryawanshi, S., Feldstein, A., Haskell, W. L., Hochberg, M. C., Torner, J. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040326 · Cited by 275
Biochemical markers of bone turnover – uses and limitations
Hlaing, T. T., & Compston, J. E. (2014) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563213515190 · Cited by 265
Markers of Bone Turnover Predict Postmenopausal Forearm Bone Loss Over 4 Years: The OFELY Study
Garnero, P., Sornay-Rendu, E., Duboeuf, F., & Delmas, P. D. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1614 · Cited by 256
Self-citationGallego-Rojo, F. J., Gonzalez-Calvin, J. L., Muñoz-Torres, M., Mundi, J. L., Fernandez-Perez, R., & Rodrigo-Moreno, D. (1998) · Hepatology · doi:10.1002/hep.510280315 · Cited by 241
Caillot-Augusseau, A., Vico, L., Heer, M., Voroviev, D., Souberbielle, J.-C., Zitterman, A., Alexandre, C., & Lafage-Proust, M.-H. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.8.1136 · Cited by 133
“The intra- and interassay CVs were ,7% and 9%, respectively ( 17 ). Expected values are 8 ‐16.6 mg/L.”
BackgroundInfluentialBurch, J., Rice, S., Yang, H., Neilson, A., Stirk, L., Francis, R., Holloway, P., Selby, P., & Craig, D. (2014) · Health Technology Assessment · doi:10.3310/hta18110 · Cited by 132
Parathyroid hormone and physical exercise: a brief review.
(2006) · Europe PMC (PubMed Central) · Cited by 63
Metadata
- Authors
- Garnero, P.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1993-10-01
- Volume
- 77
- Issue
- 4
- Pages
- 1046-1053
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2002764204
- Cited by
- 362
- References
- 17
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.